Hannes smarason next code-wuxi combined technologiesHannes Smárason
Lower-cost genome sequencing has reached a point of strong commercial viability. The remaining 2 legs of the “3-legged stool” of genomics-enabling technologies —genomic analysis tools database storage—are rapidly evolving to support the use of genomic information in medical care.
Hannes Smarason: Progress & Prospects in GenomicsHannes Smárason
The annual American Society of Human Genetics Meeting (ASHG 2016) is an excellent time for the field of genomics to take stock of the past and clarify our perspectives for the future.
Maintaining Momentum Post-ASHG 2014: Maximizing the Value of Large Genomic D...Hannes Smárason
The Haplotype Reference Consortium (HRC) unveiled at the American Society of Human Genetics (ASHG) 2014 aims to become the world’s most comprehensive database of genetic variations. The newly launched NextCODE Exchange will provide a browser-based hub for multi-center sharing and collaboration on collective genomic data from massive whole-genome databases like the HRC to accelerate research worldwide.
Genomics: Big Data Leading to Big OpportunitiesHannes Smárason
The accumulation of genomic data is a worldwide phenomenon. Cloud-based platforms such as WuXi NextCODE’s Exchange are essential to address the fundamental big data challenge of genomics.
Hannes smarason next code-wuxi combined technologiesHannes Smárason
Lower-cost genome sequencing has reached a point of strong commercial viability. The remaining 2 legs of the “3-legged stool” of genomics-enabling technologies —genomic analysis tools database storage—are rapidly evolving to support the use of genomic information in medical care.
Hannes Smarason: Progress & Prospects in GenomicsHannes Smárason
The annual American Society of Human Genetics Meeting (ASHG 2016) is an excellent time for the field of genomics to take stock of the past and clarify our perspectives for the future.
Maintaining Momentum Post-ASHG 2014: Maximizing the Value of Large Genomic D...Hannes Smárason
The Haplotype Reference Consortium (HRC) unveiled at the American Society of Human Genetics (ASHG) 2014 aims to become the world’s most comprehensive database of genetic variations. The newly launched NextCODE Exchange will provide a browser-based hub for multi-center sharing and collaboration on collective genomic data from massive whole-genome databases like the HRC to accelerate research worldwide.
Genomics: Big Data Leading to Big OpportunitiesHannes Smárason
The accumulation of genomic data is a worldwide phenomenon. Cloud-based platforms such as WuXi NextCODE’s Exchange are essential to address the fundamental big data challenge of genomics.
Genomics: Shifting the Paradigm for Rare DiseasesHannes Smárason
As genomics is used more and supported by ever-more robust analysis and interpretation, its potential to offer a solution to rare disease diagnosis is truly game-changing.
Ethical, Legal, and Social Implications of ELSI Learning Health Systems 2017 Conference, University of Michigan. Learning from the experience and outcomes of every cancer patient
Data sharing drivers in precision oncology, biomedical research, and healthcare. Accelerating discovery, innovation, providing credit for all stakeholders - patients, researchers, care providers, payers.
Genome sequencing technology available today can accurately sequence a whole genome from an individual’s test sample for a surprisingly low cost.
As a result, the adoption of this technology is rapidly expanding as medical centers around the world embrace its utility in informing healthcare decisions—an emerging reality of personalized medicine.
Pace of technology innovation, changes in publication, separating data generation from publishing insights. Given at the 2018 VIVO conference at Duke University.
TreatmentMAP™
TreatmentMAP supports physicians in optimizing their treatment decisions, even for cancer patients in advanced stages of cancer, or when all of the standard treatment options for a patient have been exhausted.
Why genomics needs telehealth to succeed - Lisa Alderson, Genome Medical - TFSSVSee
Genomics has the potential to revolutionize the practice of medicine by individualizing health care based on an exact knowledge of one's genetic predispositions. Learn why there is currently no sustainable business model to allow for this and how telehealth could be the first step to making personal genomics a part of everyday health care - from the Telehealth Failures & Secrets To Success Conference: vsee.com/telehealth-failures-conference
Overview about Caris Life Sciences, a biotech company headquartered in Irving, Texas USA specializing in precision medicine using tumor profiling to aid oncologists in the selection of cancer therapy.
OSU Medical Center CEO Steven Gabbe, MD delivers a talk on facilitating learning healthcare systems: Focus on approaches to leverage Health IT investments for advancements in research and personalized healthcare and learning from every patient.
This session will focus on the usages of HIT to learn from every patient so that this knowledge can be used to further the practice of medicine. The discussion will address the implications for research, privacy, and HIT to change the paradigm of advancing healthcare discoveries so that it is a continuous process driven through every patient interaction.
Why Precision Medicine and Personalized Healthcare and Why Now? Links to Canada’s Rare Disease Strategy The Future is Now
1) Marc LePage, Genome Canada
2) Michael Duong, Roche
3) Danica Stanimirovic, National Research Council
4) Daniel Gaudet, University of Montreal
5) Christine Dalgleish, Patient Perspective
6) Jamie Bruce, Khure Health
Strand featured in CIO Review: Pharma and Life Science Special edition - July 2014
Strand Genomics Inc recognised by CIO Review as one among 20 most promising Tech solution providers to Pharma and Life science industry 2014
Genomics: Shifting the Paradigm for Rare DiseasesHannes Smárason
As genomics is used more and supported by ever-more robust analysis and interpretation, its potential to offer a solution to rare disease diagnosis is truly game-changing.
Ethical, Legal, and Social Implications of ELSI Learning Health Systems 2017 Conference, University of Michigan. Learning from the experience and outcomes of every cancer patient
Data sharing drivers in precision oncology, biomedical research, and healthcare. Accelerating discovery, innovation, providing credit for all stakeholders - patients, researchers, care providers, payers.
Genome sequencing technology available today can accurately sequence a whole genome from an individual’s test sample for a surprisingly low cost.
As a result, the adoption of this technology is rapidly expanding as medical centers around the world embrace its utility in informing healthcare decisions—an emerging reality of personalized medicine.
Pace of technology innovation, changes in publication, separating data generation from publishing insights. Given at the 2018 VIVO conference at Duke University.
TreatmentMAP™
TreatmentMAP supports physicians in optimizing their treatment decisions, even for cancer patients in advanced stages of cancer, or when all of the standard treatment options for a patient have been exhausted.
Why genomics needs telehealth to succeed - Lisa Alderson, Genome Medical - TFSSVSee
Genomics has the potential to revolutionize the practice of medicine by individualizing health care based on an exact knowledge of one's genetic predispositions. Learn why there is currently no sustainable business model to allow for this and how telehealth could be the first step to making personal genomics a part of everyday health care - from the Telehealth Failures & Secrets To Success Conference: vsee.com/telehealth-failures-conference
Overview about Caris Life Sciences, a biotech company headquartered in Irving, Texas USA specializing in precision medicine using tumor profiling to aid oncologists in the selection of cancer therapy.
OSU Medical Center CEO Steven Gabbe, MD delivers a talk on facilitating learning healthcare systems: Focus on approaches to leverage Health IT investments for advancements in research and personalized healthcare and learning from every patient.
This session will focus on the usages of HIT to learn from every patient so that this knowledge can be used to further the practice of medicine. The discussion will address the implications for research, privacy, and HIT to change the paradigm of advancing healthcare discoveries so that it is a continuous process driven through every patient interaction.
Why Precision Medicine and Personalized Healthcare and Why Now? Links to Canada’s Rare Disease Strategy The Future is Now
1) Marc LePage, Genome Canada
2) Michael Duong, Roche
3) Danica Stanimirovic, National Research Council
4) Daniel Gaudet, University of Montreal
5) Christine Dalgleish, Patient Perspective
6) Jamie Bruce, Khure Health
Strand featured in CIO Review: Pharma and Life Science Special edition - July 2014
Strand Genomics Inc recognised by CIO Review as one among 20 most promising Tech solution providers to Pharma and Life science industry 2014
As we understand more about the human body and how it functions and degrades, biotechnology will progress. This is only the beginning, but when new technology and procedures become accessible, certain themes will start to develop in biopharma trends.
Powering the Future of Healthcare in Asia - ETPL "IOT FOR HEALTH" PROGRAM | T...Julien de Salaberry
Presentation on the importance and impact of IoT Healthcare / Healthtech on the delivery of healthcare in Asia to the ETPL "IOT FOR HEALTH" PROGRAM cohort
#healthtechasia
Domainex Ltd, the leading UK-based drug discovery CRO, has won the 2010 Genesis Life Science Innovation and Enterprise Programme Of The Year Award. This Award was made in recognition of Domainex’s proactive work on promoting academic-industry collaborations, and was adjudicated by leading representatives of the biotechnology and pharmaceutical industries.
IVD Market Competitive Research And Precise Outlook 2023 To 2030subishsam
The research firm Contrive Datum Insights has just recently added to its database a report with the heading global IVD Market . Both primary and secondary research methodologies have been utilised in order to conduct an analysis of the worldwide IVD Market . In order to provide a comprehensive comprehension of the topic at hand, it has been summed up using appropriate and accurate market insights. According to Contrive Datum Insights, this worldwide comprehensive report is broken up into several categories in order to present the data in a way that is understandable, succinct, and presented in a professional manner. This expansion can be ascribed to an increase in IVD use as a result of greater testing brought on by the epidemic.
EuroBioForum 2013 - Day 1 | Etienne RicherEuroBioForum
EuroBioForum 2013 2nd Annual Conference
27-28 May 2013 - Hilton Munich City, Munich, Germany
http://www.eurobioforum.eu/2013
=======================================
# NATIONAL PERSPECTIVES #
Canada:
Personalised Medicine: A Canadian Collaborative Perspective'
Dr Étienne Richer, Assistant Director at CIHR Institute of Genetics
=======================================
http://www.eurobioforum.eu
Future Watch summary: Future growth opportunities in global biobanks marketTeam Finland Future Watch
This Future Watch report compares the current status of forerunning biobanks in Finland, Denmark, Sweden, UK and USA, analyze the needs and views of key biobank customer segments as well as offer key recommendations for Finnish biobank to gain a larger footprint in the biobank market.
Thomas Willkens-El impacto de las ciencias ómicas en la medicina, la nutrició...Fundación Ramón Areces
El 29 de marzo de 2016 celebramos un Simposio Internacional sobre el 'Impacto de las ciencias ómicas en la medicina, nutrición y biotecnología'. Organizado por la Fundación Ramón Areces en colaboración con la Real Academia Nacional de Medicina y BioEuroLatina, abordó cómo un mejor conocimiento del genoma humano está permitiendo notables avances hacia una medicina de precisión.
Find out about collaboration and partnership opportunities with the Wellcome Sanger Institute that aims to create exceptional healthcare opportunities for everyone from extraordinary science.
The Pistoia Alliance is examining the challenges of the Faster Safe Companion Diagnostics (CDx) by Aligning Discovery & Clinical Data in the Regulatory Domain.
The slides discuss whether the data standards used in the research environment be aligned better with the data standards used in the regulated environment? If so, the time and cost of the development of NGS-based CDx could be reduced.
- Discover new methods for managing clinical next-gen data with insights from Pfizer, Boston Children’s Hospital and AstraZeneca
- Uncover and critique the latest technologies out there for you to use in clinical trials. Mayo Clinic, Merck and Harvard Medical School let you into their trade secrets
- Hear the genomics strategies that Roche, Millennium and Regeneron are using for discovery and validation of clinically actionable biomarkers
-Bristol-Myers Squibb, Takeda and Partners Healthcare the role that NGS can play when implementing an effective strategy in the lab to speed up CDx development
- Learn how to integrate molecular details into medical decision making, with fresh data from Washington University School of Medicine and Genzyme
CORD Rare Drug Conference, June 8 - 9, 2022
Opportunities and Challenges for Data Management Real-World Data and Real-World Evidence
• Patient support programs: Sandra Anderson, Innomar Strategies
• AI for Data Management and Enhancement: Aaron Leibtag, Pentavere
• Patient Support and RWE: Laurie Lambert, CADTH
Precision and Participatory Medicine - Medinfo 2015 Panel on big data. Includes the proposal to use the term Expotype to characterise the Exposome of an individual. Electronic expo typing would refer to the automatic construction of individual expo types from electronic clinical records and other sources of environmental risk factor and exposure data.
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
The Gram stain is a fundamental technique in microbiology used to classify bacteria based on their cell wall structure. It provides a quick and simple method to distinguish between Gram-positive and Gram-negative bacteria, which have different susceptibilities to antibiotics
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Genomics-Based Medicine Coming into View
1. Genomics-Based Medicine
Coming into View
Hannes Smarason
Genome Sequencing |Personalized Medicine | Transforming Health Care
2. The practice and adoption of genomic medicine is
accelerating as technologies improve, costs fall and
new insights drive better patient care. While many
companies are supporting this emerging field, a select
few are providing the unique perspectives and
capabilities to advance progress even faster.
3. Progress in Action
• NextCODE Health made headlines less than a year ago with its
launch and funding announcement.
• The company quickly gained recognition for its unique
capabilities to address unmet needs in the genomics space
through a massive genomics database that interprets DNA
samples to identify relevant disease markers. (See the
features in Xconomy, Bio-IT World and PLOS Blog.)
• The company was later mentioned in Nature Biotechnology
News for its potential contributions to genome studies by
leveraging reference data from deCODE’s Icelandic database.
4. Accelerating Progress
• Its rapid trajectory since launch and the utility of its genomic analysis
technology was featured in BioCentury in May, with testimonials from
clinicians using NextCODE capabilities.
• In June, it was featured in a major interview with Bio-IT World, and the
company continues to expand.
• Since then, NextCODE has announced several programs through which
world leaders in genomics research are applying its interpretation and
analysis technology:
– A collaboration with the ANZAC Research Institute in Sydney Australia to use
NextCODE’s technology to research a rare disease, X-linked Charcot-Marie-
Tooth syndrome
– And a new program with University College Dublin’s ACoRD to study autism
and rare diseases
5. As more organizations employ
genomics in major research initiatives,
NextCODE’s interpretation technology will
be an increasingly important asset in
delivering meaningful insights from the
wealth of genomic data being produced.